相关实验视频

Updated: May 27, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

使用网络药理学和实验性大鼠模型,评估沙利德化物作为血管化的治疗剂

Han-Ying Xu¹, Xiao-Lei Tang², Peng-Fei Li³

¹Department of Encephalopathy, The Affiliated Hospital of Changchun University of Chinese Medicine.

Journal of visualized experiments : JoVE

|February 17, 2025

概括

沙利德 (SAL) 通过调节脂质和炎症因素,有效治疗血管化 (VC). 这种天然化合物激活JAK2/STAT3通路,减少血管炎症和沉积.

科学领域:

药理学药理学是指药理学的学科.
分子生物学分子生物学
心血管研究研究心血管研究

背景情况:

血管化 (VC) 是一个与高发病率和死亡率相关的重大健康问题.
了解像沙利德化物 (SAL) 这样的天然化合物的治疗机制,对于开发新的VC治疗方法至关重要.

研究的目的:

通过混合网络药理学和分子生物学方法研究沙利德 (SAL) 对血管化 (VC) 的治疗机制.
确定关键的分子点和涉及SAL抗VC效应的途径.

主要方法:

网络药理学分析以确定SAL和VC之间的共同目标.
蛋白与蛋白相互作用 (PPI) 网络构建和拓分析以确定关键目标.
功能丰富分析以确定涉及的途径 (例如,脂质代谢,炎症).
在老鼠体内进行实验,以验证SAL的疗效和机械作用.

主要成果:

确定了SAL和VC之间的208个共同目标,其中主要目标包括IL6,TNF,TP53,IL1B,HIF1A,CASP3和STAT3.
在体内,SAL在减轻脂质不良和血管炎症方面表现出有效性.
发现SAL可以抑制炎症因素并激活JAK2/STAT3信号通路,这是防止VC进展的关键机制.

结论:

沙利多 (SAL) 通过调节脂质和炎症通路,对血管化 (VC) 具有治疗潜力.
JAK2/STAT3信号通路是一个关键的分子机制,通过它,SAL对VC产生保护作用.
这项研究为探索天然化合物作为血管化的潜在治疗剂提供了坚实的框架.

更多相关视频

Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification

Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification

Published on: November 20, 2017

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Published on: January 27, 2023

相关概念视频

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

Antihypertensive Drugs: Vasodilators

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...